NCT00056849View on ClinicalTrials.gov

Genetic Determinants of Ankylosing Spondylitis Severity

CompletedOBSERVATIONAL
Enrollment

134

Participants

Timeline

Start Date

March 24, 2003

Primary Completion Date

January 3, 2020

Study Completion Date

January 3, 2020

Conditions
Ankylosing Spondylitis
Trial Locations (1)

90048-1804

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

NCT00056849 - Genetic Determinants of Ankylosing Spondylitis Severity | Biotech Hunter | Biotech Hunter